| Drug Name: | Milrinone (78415-72-2) |
|---|---|
| PubChem ID: | 4197 |
| SMILES: | CC1=C(C=C(C(=O)N1)C#N)C2=CC=NC=C2 |
| InchiKey: | PZRHRDRVRGEVNW-UHFFFAOYSA-N |
| Therapeutic Category: | Cardiotonic Agents, Cardiovascular Agents, Enzyme Inhibitors, Hematologic Agents, Phosphodiesterase 3 Inhibitors, Phosphodiesterase Inhibitors, Platelet Aggregation Inhibitors, Protective Agents, Vasodilator Agents |
| Molecular Weight (dalton) | : | 211.224 |
| LogP | : | 1.617 |
| Ring Count | : | 2 |
| Hydrogen Bond Acceptor Count | : | 3 |
| Hydrogen Bond Donor Count | : | 1 |
| Total Polar Surface Area | : | 69.54 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category